FDA Drug Application (060254) for DYCILL by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number060254
Product Number002
FormCAPSULE;ORAL
DosageEQ 250MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDYCILL
Active IngredientDICLOXACILLIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient DICLOXACILLIN SODIUM4


Back to FDA Applications sponsored by GLAXOSMITHKLINE